Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor.
Market Cap | 55.141 Million | Shares Outstanding | 36.277 Million | Avg 30-day Volume | 101.799 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.16 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -44.705 Million |
Price to Book Value | 0.6201 | Operating Margin | 0.0 | Enterprise Value | -34.744 Million |
Current Ratio | 29.692 | EPS Growth | 0.609 | Quick Ratio | 28.958 |
1 Yr BETA | 1.1372 | 52-week High/Low | 3.35 / 0.54 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 51.82 | Altman Z-Score | 5.841 | Free Cash Flow to Firm | -34.02 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
0 | 2023-05-24 | 2 | |
|
0 | 2023-05-24 | 2 | |
|
0 | 2023-05-24 | 2 | |
|
0 | 2023-05-24 | 2 | |
|
0 | 2023-05-24 | 3 | |
MONOHON TED CHIEF ACCOUNTING OFFICER & VP |
|
27,440 | 2023-03-06 | 5 |
THYE DIRK CHIEF EXECUTIVE OFFICER |
|
0 | 2023-02-01 | 1 |
SMITH KAREN L. CHIEF MEDICAL OFFICER |
|
0 | 2023-02-01 | 1 |
HANNAH BRENDAN CHIEF BUSINESS OFFICER |
|
0 | 2023-02-01 | 1 |
MCDOWELL CARYN GORDON CHIEF LEGAL & ADM. OFFICER |
|
122,500 | 2022-06-06 | 0 |
HOLSINGER LESLIE EVP, PRECLINICAL DEVELOPMENT |
|
148,080 | 2022-06-06 | 0 |
|
0 | 2022-05-19 | 0 | |
|
0 | 2022-03-14 | 0 | |
LOWE CHRISTOPHER P. INTERIM CEO, COO & CFO |
|
265,000 | 2022-03-03 | 0 |
DETKE MICHAEL J. CHIEF MEDICAL OFFICER |
|
140,000 | 2022-03-03 | 0 |
LYNCH CASEY CHIEF EXECUTIVE OFFICER |
|
440,000 | 2022-01-03 | 0 |
DOMINY STEPHEN S. CHIEF SCIENTIFIC OFFICER |
|
125,000 | 2022-01-03 | 0 |
|
No longer subject to file | 2020-12-31 | 0 | |
|
0 | 2020-06-08 | 0 | |
GAFRIC KRISTEN SVP, LEGAL & ADMINISTRATION |
|
0 | 2020-02-06 | 0 |
|
3,249,973 | 2019-05-13 | 0 | |
|
No longer subject to file | 2014-02-03 | 0 | |
|
15,000 | 2007-05-02 | 0 | |
|
15,000 | 2007-05-02 | 0 | |
|
15,000 | 2007-05-02 | 0 | |
|
15,000 | 2007-05-02 | 0 | |
|
7,500 | 2007-05-02 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-26 17:45:03 -0400 | 2023-05-24 | A | 27,000 | a | 27,000 | direct | ||||||||||
2023-05-26 17:47:13 -0400 | 2023-05-24 | A | 27,000 | a | 27,000 | direct | ||||||||||
2023-05-26 17:49:15 -0400 | 2023-05-24 | A | 27,000 | a | 27,000 | direct | ||||||||||
2023-05-26 17:50:54 -0400 | 2023-05-24 | A | 27,000 | a | 27,000 | direct | ||||||||||
2023-05-26 17:53:52 -0400 | 2023-05-24 | A | 27,000 | a | 27,000 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 22:15:04 UTC | -25.4728 | 30.5428 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 21:45:05 UTC | -25.4728 | 30.5428 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 21:15:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 20:45:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 20:15:06 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 19:45:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 19:15:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 18:45:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 18:15:03 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 17:45:05 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 17:15:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 16:45:03 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 16:15:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 15:45:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 15:15:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 14:45:04 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 14:15:03 UTC | -25.377 | 30.447 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 13:45:03 UTC | -25.142 | 30.212 | 500000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 13:15:04 UTC | -25.142 | 30.212 | 550000 |
QUINCE THERAPEUTICS INC QNCX | 2023-06-07 12:45:04 UTC | -25.142 | 30.212 | 500000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|